History
  • No items yet
midpage
977 F.3d 1224
Fed. Cir.
2020
Read the full case

Background

  • Medtronic and Dr. Rick Sasso contracted (Facet Screw Agreement, Dec. 1, 1999) to pay royalties through the later of patent expiration or seven years from first sale; payments required coverage by a "valid claim."
  • Two patents issued from the original application: U.S. Patent Nos. 6,287,313 and 6,562,046; Medtronic paid royalties from 2002–2018 but dispute arose over additional devices not listed in contract schedules.
  • Sasso sued in Indiana state court for breach of contract; the state court ruled that issuance (not validity) controls the Agreement term, excluded evidence of patent invalidity, and a jury awarded Sasso damages; that judgment is on appeal.
  • Medtronic sued in federal district court for declaratory judgment that it did not breach because the asserted patents/claims do not validly cover the disputed products or are invalid; the PTO later canceled many of the claims in reexamination.
  • The district court dismissed Medtronic’s federal declaratory action without prejudice under Wilton/Brillhart abstention, reasoning the state-court contract judgment made federal relief unnecessary (appeal pending); Medtronic appealed.
  • The Federal Circuit held it had jurisdiction, found the district court had discretion under Wilton/Brillhart, and affirmed dismissal as not an abuse of discretion on these facts.

Issues

Issue Plaintiff's Argument (Medtronic) Defendant's Argument (Sasso) Held
1) Was dismissal/abstention an abuse of discretion? Dismissal was improper because federal courts have exclusive patent jurisdiction and patent validity is central to the contract claim. District court properly exercised Wilton/Brillhart discretion because state case produced a final judgment on the contract and appeal is pending. Affirmed: district court did not abuse discretion in dismissing without prejudice under Wilton/Brillhart given the state-court judgment and posture.
2) Does the declaratory complaint "arise under" patent law so federal courts/Federal Circuit have jurisdiction? Counts necessarily raise patent validity and claim scope, so federal-question jurisdiction (28 U.S.C. § 1338) and Federal Circuit review apply. State-law contract governs royalties; issuance vs. validity is a state-law contract interpretation, so no federal "arising under." Federal jurisdiction exists for the declaratory claims; the Federal Circuit had appellate jurisdiction to review the abstention decision.
3) Did the state court’s exclusion of patent-invalidity defenses deprive Medtronic of an adequate forum, requiring federal adjudication? State court excluded invalidity evidence, producing an unfair result and leaving Medtronic unable to resolve federal patent-based defenses. Contract disputes are principally state-law matters; state process and appellate review can address errors. Abstention was still proper here—district court reasonably declined to entertain declaratory relief given the state judgment and ongoing state appeal.
4) Do PTO reexamination cancellations of claims change the need for federal adjudication? Reexamination cancelled the claims covering disputed devices, bearing on the Agreement’s "valid claim coverage" term and supporting federal resolution. District court deemed the PTO action not dispositive to the abstention decision at that time. PTO cancellations were noted but did not make dismissal an abuse of discretion under the circumstances; dismissal was without prejudice.

Key Cases Cited

  • Wilton v. Seven Falls Co., 515 U.S. 277 (1995) (Declaratory Judgment Act confers discretionary authority to decline declaratory relief)
  • Brillhart v. Excess Ins. Co. of Am., 316 U.S. 491 (1942) (federal courts may abstain when parallel state proceedings can better resolve the dispute)
  • Colorado River Water Conservation Dist. v. United States, 424 U.S. 800 (1976) (abstention is an extraordinary exception appropriate only in exceptional circumstances)
  • Gunn v. Minton, 568 U.S. 251 (2013) (limits on when state-law claims that implicate patent questions "arise under" federal patent law)
  • Grable & Sons Metal Prods., Inc. v. Darue Eng'g & Mfg., 545 U.S. 308 (2005) (federal-question jurisdiction over state-law claim requires a substantial federal issue)
  • NeuroRepair, Inc. v. Nath Law Group, 781 F.3d 1340 (Fed. Cir. 2015) (analyzing when patent issues are necessarily raised for federal jurisdiction)
  • Capo, Inc. v. Dioptics Med. Prods., Inc., 387 F.3d 1352 (Fed. Cir. 2004) (abuse of discretion to dismiss declaratory action when dismissal leaves accused infringer unable to resolve liability)
  • Jang v. Boston Sci. Corp., 767 F.3d 1334 (Fed. Cir. 2014) (dismissal improper where contract resolution requires resolving infringement or validity and could produce divergent future judgments)
  • Envision Healthcare, Inc. v. PreferredOne Ins. Co., 604 F.3d 983 (7th Cir. 2010) (Wilton/Brillhart abstention doctrine explained and applied)
  • Sony Elecs., Inc. v. Guardian Media Techs., Ltd., 497 F.3d 1271 (Fed. Cir. 2007) (abuse-of-discretion standard for appellate review of Wilton/Brillhart dismissals)
Read the full case

Case Details

Case Name: Warsaw Orthopedic, Inc. v. Sasso
Court Name: Court of Appeals for the Federal Circuit
Date Published: Oct 14, 2020
Citations: 977 F.3d 1224; 19-1583
Docket Number: 19-1583
Court Abbreviation: Fed. Cir.
Log In